-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PYkIjw5WT5HSI2IX4mPzjo74k23BssyMGJyWJn87DrtU0M3feIN9/r6LOgCrFejw 3qGQzYoKcJAvFdgRaZN+fw== 0000898432-02-000473.txt : 20020715 0000898432-02-000473.hdr.sgml : 20020715 20020715165813 ACCESSION NUMBER: 0000898432-02-000473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020630 FILED AS OF DATE: 20020715 COMPANY DATA: COMPANY CONFORMED NAME: KIMBERLIN KEVIN CENTRAL INDEX KEY: 0000904841 DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: SPENCER TRASK SECURITIES INC STREET 2: 535 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123555565 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNE RESPONSE CORP CENTRAL INDEX KEY: 0000817785 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330255679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18006 FILM NUMBER: 02703201 BUSINESS ADDRESS: STREET 1: 5935 DARWIN COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 6194317080 MAIL ADDRESS: STREET 1: 5935 DARWIN COURT CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 kimberlin-4.txt JUNE 2002
- ------------------------ FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION ----------------------------- - ------------------------ WASHINGTON, D.C. 20549 OMB APPROVAL ----------------------------- [ ]Check this box if STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287 no longer subject Expires: January 31, 2005 to Section 16. Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Estimated average Form 4 or Form 5 Section 17(a) of the Public Utility Holding Company Act of 1935 or burden hours per obligations may Section 30(f) of the Investment Company Act of 1940 response: 0.5 continue. ----------------------------- SEE Instruction 1(b) (Print or Type Response) - ----------------------------------------------------------------------------------------------------------------------------------- 1. Name and Address of Reporting 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person* Person(s) to Issuer Kimberlin Kevin B. The Immune Response Corporation (Check all applicable) - -------------------------------------------------------------------------------------- (Last) (First) (Middle) 3. IRS or Social 4. Statement for X Director X 10% Owner Security Number Month/Year --- --- of Reporting Officer (give Other specify Person June 2002 ___ (title below) ____ (below (Voluntary) below) 535 Madison Avenue 18th Floor - ----------------------------------------------------------------------------------------------------------------------------------- (Street) 5. If Amendment, 7. Individual or Joint/Group Date of Original Filing (Check Applicable Line) (Month/Year) X Form filed by One Reporting Person --- New York NY 10022 Form filed by More than One Reporting ___ Person - ----------------------------------------------------------------------------------------------------------------------------------- (City) (State) (Zip) TABLE 1 - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED - ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Trans- 3. Trans 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature (Instr. 3) action action or Disposed of (D) Securities ship- of Date Code (Instr. 3, 4 and 5) Beneficially Form: Indirect (Instr. 8) Owned at Direct Beneficial End of Month (D) or Owner- Indirect ship --------------------------------------- (I) (Month/ (A) Day/ or Year Code V Amount (D) Price (Instr. 3 and 4) (Instr. 4) (Instr. 4) ---------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock, par value $.0025 per share 35,000 I See Note (1) - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock, par value $.0025 per share 16,000 I See Note (2) - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock, par value $.0025 per share 227,000 I See Note (3) - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock, par value $.0025 per share See Note (4) 1,794,871 I See Note (4) - ----------------------------------------------------------------------------------------------------------------------------------- 1. Held by the reporting person's spouse. 2. Held in a retirement account for the benefit of the reporting person. 3. Held by Kimberlin Family Partners L.P. a Colorado limited partnership, of which the reporting person is the general partner. 4. The reported securities were included in Units, each of which included one share of the Issuer's common stock and one warrant to purchase one share of the Issuer's common stock (which warrants have subsequently expired), purchased in 1997 for $7.80 per Unit by Kevin Kimberlin Partners, L.P., a Delaware limited partnership, of which the general partner is KKP Management LLC, a Nevada limited liability company, of which the reporting person is the managing member. - ----------------------------------------------------------------------------------------------------------------------------------- Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) * If the form is filed by more than one reporting person, SEE Instruction 4(b)(v). SEC 1474 (7-96)
FORM 4 (continued) TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) - ---------------------------------------------------------------------------------------------------------------------------------- 1.Title of 2.Conver- 3.Trans- 4.Trans- 5.Number of 6.Date Exer- 7.Title 8.Price 9.Number 10.Owner- 11.Nature Derivative sion or action action of Deriv- cisable and and of of ship of Security Exercise Date Code ative Expiration Amount Deriv- Deriv- Form of Indirect (Instr. 3) Price of (Instr. Securities Date (Month/ of ative ative Deriv- Benefi- Deriva- (Month/ 8) Acquired Day/ Under- Secur- Secur- ative cial tive Day/ (A) or Dis- Year) lying) ity ities Secur- Owner- Security Year) posed of (D) Securi- Instr. Benefi- ity: ship (Instr. 3, ties 5) cially Direct (Instr. 4) 4 and 5) (Instr. owned (D) or 3 and 4) at end Indirect of month (I) (Instr. 4) -------------------------------------------------------------------- Date Expira- Amount or Exer- tion Number of Code V (A) (D) isable Date Title Shares - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $18.25 12/15/92 A Immed. 12/15/02 Stock 25,000 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $8.00 9/19/94 A Immed. 9/19/04 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $5.44 6/14/95 A Immed. 6/14/05 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $12.25 5/30/96 A Immed. 5/30/06 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $8.75 5/22/97 A Immed. 5/22/07 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $13.69 6/11/98 A Immed. 6/11/08 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $7.3125 5/25/99 A Immed. 5/25/09 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $5.78125 8/17/99 A Immed. 8/17/09 Stock 4,719 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $5.9380 5/25/00 A Immed. 5/25/10 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $3.9380 11/27/00 A Immed. 11/27/10 Stock 29,367 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy See Common Common Stock $3.9380 11/14/00 A Note(5) 11/14/10 Stock 70,638 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $3.450 6/21/01 A 6/22/02 6/22/11 Stock 6,250 D - ------------------------------------------------------------------------------------------------------------------------------- Option to buy Common Common Stock $0.59 6/17/02 A 6/17/03 6/17/12 Stock 6,250 148,542 D - ------------------------------------------------------------------------------------------------------------------------------- 8% Convertible Deben- Common See Note ture due 2004 $1.1536 11/9/01 P 1,733,703 Immed. Stock 1,733,703 I (6) - ------------------------------------------------------------------------------------------------------------------------------- Warrant to buy Common See Note Common Stock $1.4420 11/9/01 P 1,733,703 Immed. 11/19/11 Stock 1,733,703 3,467,406 I (6) - ------------------------------------------------------------------------------------------------------------------------------- 8% Convertible Deben- Common See Note ture due 2005 $1.036 02/14/02 P 1,716,001 Immed. 11/27/10 Stock 1,716,001 I (7) - ------------------------------------------------------------------------------------------------------------------------------- Warrant to buy Common See Note Common Stock $1.1655 02/14/02 P 1,716,001 Immed. 02/14/12 Stock 1,716,001 3,432,002 I (7) - ------------------------------------------------------------------------------------------------------------------------------- 8% Convertible Deben- Common See Note ture due 2005 $0.432 05/03/02 P 9,276,437 Immed. Stock 9,276,437 I (8) - ------------------------------------------------------------------------------------------------------------------------------- Warrant to buy Common See Note Common Stock $0.54 05/03/02 P 9,276,437 Immed. 05/03/12 Stock 9,276,437 18,552,874 I (8) - ------------------------------------------------------------------------------------------------------------------------------- 8% Convertible Deben- Common See Note ture due 2005 $0.4776 06/24/02 P 2,093,802 Immed. Stock 2,093,802 I (9) - ------------------------------------------------------------------------------------------------------------------------------- Warrant to buy Common See Note Common Stock $0.597 06/24/02 P 2,093,802 Immed. 06/24/12 Stock 2,093,802 4,187,604 I (9) - ------------------------------------------------------------------------------------------------------------------------------- Explanation of Responses: (5) An equal portion of the options to purchase 70,638 shares of the Issuer's common stock, which were granted to the reporting person on November 14, 2000, vest each day that the reporting person remains a member of the Issuer's board of directors, with the entire grant to become fully vested on January 1, 2003. (6) On November 9, 2001, Kevin Kimberlin Partners, L.P., a Delaware limited partnership, of which the general partner is KKP Management LLC, a Nevada limited liability company, of which the reporting person is the managing member, purchased (a) a promissory note initially convertible into 1,733,703 shares of the Issuer's common stock and (b) a warrant to purchase 1,733,703 shares of the Issuer's common stock. (7) On February 14, 2002, Oshkim Limited Partnership, of which the reporting person is an affiliate, purchased (a) a promissory note initially convertible into 1,716,001 shares of the Issuer's common stock and (b) a warrant to purchase 1,716,001 shares of the Issuer's common stock. (8) On May 3, 2002, Oshkim Limited Partnership, of which the reporting person is an affiliate, purchased (a) a promissory note initially convertible into 9,276,437 shares of the Issuer's common stock and (b) a warrant to purchase 9,276,437 shares of the Issuer's common stock. (9) On June 24, 2002, Oshkim Limited Partnership, of which the reporting person is an affiliate, purchased (a) a promissory note initially convertible into 2,093,802 shares of the Issuer's common stock and (b) a warrant to purchase 2,093,802 shares of the Issuer's common stock. The promissory note is alternatively convertible (at the option of the reporting person and subject to the receipt of all necessary corporate and regulatory approvals) into 10 units (rather than the Issuer's common stock) to be sold by the Issuer as part of a contemplated private offering of units comprised of the Issuer's common stock and warrants. - ------------------------------------------------------------------------------------------------------------------------------- ** Intentional misstatements or omissions of facts constitute /s/ Kevin B. Kimberlin July 15, 2002 Federal Criminal Violations. ------------------------------------ ----------------- SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). **Signature of Reporting Person Date Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, SEE Instruction 6 for procedure. Potential persons who are to respond to the collection of Page 3 of 3 information contained in this form are not required to SEC 1474 (7-96) respond unless the form displays a currently valid OMB Number.
-----END PRIVACY-ENHANCED MESSAGE-----